Shandong Freda Biotech Co., Ltd. and its medical-aesthetic skincare brand Key C announced the presentation of a novel ...
Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development ...
James Cameron's blockbuster saga returns with more battles, more eye candy, and enough déjà vu to make you feel blue ...
Microbix Biosystems Inc. ( MBX:CA) Q4 2025 Earnings Call December 18, 2025 10:00 AM EST Good morning, everyone. Thanks for joining us today. We have Microbix here to talk about their Q4 and Year-End ...
GenSci and RTW Investments announce exclusive global ex-China license agreement for GS-098: Shanghai Thursday, December 18, 2025, 17:00 Hrs [IST] Shanghai Scizeng Medical Technolo ...
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS), today ...
The FDA has approved the subcutaneous administration of a fixed combination of amivantamab (Rybrevant; Johnson & Johnson) and a recombinant human hyaluronidase for patients with non–small cell lung ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback